For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

ERK1/2-signaling in cancer

Related

  • ERK1/2 SimpleStep™ ELISA kits
    • ERK1/2 antibodies
      • Ras antibodies
        • MAPK signaling inhibitors
          • MAPK signaling - @ a glance

            by Seán Mac Fhearraigh, PhD

            [Please note, this page is no longer updated]

            The Ras-Raf-MEK-ERK/MAPK pathway is highly conserved in metazoans and controls many of the principal pathways involved in cell motility, metabolism, cell proliferation, differentiation and apoptosis [Kolch, 2005].

            Initiation of the Ras-Raf- MEK/MAPK pathway can occur through receptor tyrosine kinase (RTK) activation. RTKs act as entry points for many extracellular cues as they contain an N-terminal extracellular ligand binding domain and C-terminal intracellular tyrosine kinase domain [McKay and Morrison, 2007; Pawson, 2002].

            Upon binding of their respective ligands, RTKs undergo dimerisation and autophosphorylation of tyrosine residues within their C-terminal intracellular domain.

            View our ERK1/2 interactive pathway

            Activation of RasGTPase is a key step allowing for signal transduction from RTKs to ERK1/2 MAPK. RasGTPases are a superfamily of small monomeric GTPases which include NRAS, KRAS and HRAS [Downward, 2003].

            One of the most intensively studied activators of Ras is the SOS (Son of sevenless homologue 1) guanine nucleotide exchange factor (GEF) [Downward, 1996]. GRB2 mediates the translocation of SOS from the cytosol to the plasma membrane upon RTK activation, resulting in the activation of Ras through GTP exchange.

            Activated Ras then binds to and recruits the Raf kinase to the cell membrane. The RAF gene produces three isoforms (A-Raf, B-Raf and Raf-1), and each isoform has specific functions.

            The Raf kinase is the apical kinase in a three-tier phosphorylation activation cascade, where Raf phosphorylates and activates MEK1 and MEK2, which in turn phosphorylates activates and ERK1/2 [Vigil et al., 2010]. Once activated ERK1/2 phosphorylates a spectrum of substrates in both the cytosol and nucleus which include phosphatases, kinases, cytoskeletal proteins and transcription factors which play an integral role in cell death and cell proliferation [Yoon and Seger, 2006].

            Deregulation of the ERK pathway

            Deregulation of the ERK pathway occurs in up to one-third of all cancers. Due to its anti-apoptotic and proliferative affects, ERK1/2 is a central player in the propagation of many forms of cancer.

            ERK becomes constitutively active following aberrant expression of tyrosine kinases and following sustained paracrine or autocrine signalling, and B-Raf or Ras mutations [Dhillon et al., 2007].

            For example, malignant melanoma is a highly aggressive cancer that is resistant to chemotherapy [Houghton and Polsky, 2002]. Approximately 60% of melanomas contain somatic B-Raf missense mutations which are found within the kinase domain of B-Raf.

            The V600E missense mutation accounts for 80% of all mutations [Davies et al., 2002]. The B-RafV600E mutant results in a dramatic elevation in its kinase activity leading to increased ERK1/2 kinase activity in vivo [Wan et al., 2004].

            Tools for ERK signaling

            References

            • Davies, H., G. R. Bignell, et al. (2002). "Mutations of the BRAF gene in human cancer." Nature 417(6892): 949-54.
            • Dhillon, A. S., S. Hagan, et al. (2007). "MAP kinase signalling pathways in cancer." Oncogene 26(22): 3279-90.
            • Downward, J. (1996). "Control of ras activation." Cancer Surv 27: 87-100.
            • Downward, J. (2003). "Targeting RAS signalling pathways in cancer therapy." Nat Rev Cancer 3(1): 11-22.
            • Houghton, A. N. and D. Polsky (2002). "Focus on melanoma." Cancer Cell 2(4): 275-8.
            • Kolch, W. (2005). "Coordinating ERK/MAPK signalling through scaffolds and inhibitors." Nat Rev Mol Cell Biol 6(11): 827-37.
            • McKay, M. M. and D. K. Morrison (2007). "Integrating signals from RTKs to ERK/MAPK." Oncogene 26(22): 3113-21.
            • Pawson, T. (2002). "Regulation and targets of receptor tyrosine kinases." Eur J Cancer 38 Suppl 5: S3-10.
            • Yoon, S. and R. Seger (2006). "The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions." Growth Factors 24(1): 21-44.
            • Vigil, D., J. Cherfils, et al. "Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?" Nat Rev Cancer 10(12): 842-57.
            Get resources and offers direct to your inbox Sign up
            A-Z by research area
            • Cancer
            • Cardiovascular
            • Cell biology
            • Developmental biology
            • Epigenetics & Nuclear signaling
            • Immunology
            • Metabolism
            • Microbiology
            • Neuroscience
            • Signal transduction
            • Stem cells
            A-Z by product type
            • Primary antibodies
            • Secondary antibodies
            • Biochemicals
            • Isotype controls
            • Flow cytometry multi-color selector
            • Kits
            • Loading controls
            • Lysates
            • Peptides
            • Proteins
            • Slides
            • Tags and cell markers
            • Tools & Reagents
            Help & support
            • Support
            • Make an Inquiry
            • Protocols & troubleshooting
            • Placing an order
            • RabMAb products
            • Biochemical product FAQs
            • Training
            • Browse by Target
            Company
            • Corporate site
            • Investor relations
            • Company news
            • Careers
            • About us
            • Blog
            Events
            • Tradeshows
            • Conferences
            International websites
            • abcam.cn
            • abcam.co.jp

            Join with us

            • LinkedIn
            • facebook
            • Twitter
            • YouTube
            • Terms of sale
            • Website terms of use
            • Cookie policy
            • Privacy policy
            • Legal
            • Modern slavery statement
            © 1998-2022 Abcam plc. All rights reserved.